<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>eDietAdvice — Weight loss news</title>
    <link>https://edietadvice.com/</link>
    <description>Verified weight loss news from eDietAdvice. Entries are published only after primary-source verification.</description>
    <language>en-us</language>
    <item>
      <title>FTC, Utah, and LA County sue Hims &amp; Hers over health-data sharing and cancellation practices</title>
      <link>https://edietadvice.com/providers/hims/</link>
      <guid isPermaLink="false">2026-07-29-weight-loss-FTC, Utah, and LA County sue Hims &amp; Hers</guid>
      <pubDate>Wed, 29 Jul 2026 00:00:00 GMT</pubDate>
      <category>Weight loss</category>
      <description>The complaint targets sharing sensitive health data with ad platforms and ROSCA billing/cancellation practices — context for anyone weighing the $149/month membership model. Source: https://www.shumaker.com</description>
    </item>
    <item>
      <title>Medicare's $50/month GLP-1 Bridge copay goes live</title>
      <link>https://edietadvice.com/weight-loss/medicare-glp1-bridge/</link>
      <guid isPermaLink="false">2026-07-01-weight-loss-Medicare's $50/month GLP-1 Bridge copay </guid>
      <pubDate>Wed, 01 Jul 2026 00:00:00 GMT</pubDate>
      <category>Weight loss</category>
      <description>Participating Part D plans now cover Wegovy (pen and pill), Foundayo, and the Zepbound KwikPen at a flat $50 monthly copay through 2027 — below every cash price we track. Source: https://www.medicare.gov/coverage/weight-loss-drugs</description>
    </item>
    <item>
      <title>FDA moves to permanently end bulk compounding of semaglutide and tirzepatide</title>
      <link>https://edietadvice.com/weight-loss/compounded-glp1-503a-market/</link>
      <guid isPermaLink="false">2026-04-30-weight-loss-FDA moves to permanently end bulk compou</guid>
      <pubDate>Thu, 30 Apr 2026 00:00:00 GMT</pubDate>
      <category>Weight loss</category>
      <description>The proposed 503B Bulks List exclusion would close the mass-compounding era for good. Patient-specific 503A compounding continues — the legal market our index tracks at $139–$297 all-in. Source: https://www.fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list</description>
    </item>
    <item>
      <title>Foundayo (orforglipron) approved — the first GLP-1 pill with no food-and-water rules</title>
      <link>https://edietadvice.com/foundayo-cost/</link>
      <guid isPermaLink="false">2026-04-01-weight-loss-Foundayo (orforglipron) approved — the f</guid>
      <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
      <category>Weight loss</category>
      <description>Lilly's once-daily oral launched via LillyDirect at $149–$349/month by dose, with promo tiers through 2026. Source: https://investor.lilly.com</description>
    </item>
    <item>
      <title>Novo Nordisk and Hims &amp; Hers settle; Hims exits compounded GLP-1s</title>
      <link>https://edietadvice.com/weight-loss/glp-1-membership-fees/</link>
      <guid isPermaLink="false">2026-03-09-weight-loss-Novo Nordisk and Hims &amp; Hers settle; Him</guid>
      <pubDate>Mon, 09 Mar 2026 00:00:00 GMT</pubDate>
      <category>Weight loss</category>
      <description>The settlement ended the $49/day compounded oral semaglutide era at Hims, which now sells brand meds at manufacturer-matching prices plus its $149/month membership. Source: https://www.cnbc.com/2026/03/09/novo-nordisk-ends-legal-proceedings-hims-hers-compounded-weight-loss-drugs.html</description>
    </item>
    <item>
      <title>TrumpRx launches — a referral portal, not a pharmacy</title>
      <link>https://edietadvice.com/wegovy-cost/</link>
      <guid isPermaLink="false">2026-02-05-weight-loss-TrumpRx launches — a referral portal, no</guid>
      <pubDate>Thu, 05 Feb 2026 00:00:00 GMT</pubDate>
      <category>Weight loss</category>
      <description>The government site displays the manufacturers' lowest DTC prices and links out to NovoCare and LillyDirect. For cash buyers it changes almost nothing versus going direct. Source: https://trumprx.gov/</description>
    </item>
    <item>
      <title>Wegovy pill approved — oral semaglutide for weight loss</title>
      <link>https://edietadvice.com/wegovy-cost/</link>
      <guid isPermaLink="false">2025-12-22-weight-loss-Wegovy pill approved — oral semaglutide </guid>
      <pubDate>Mon, 22 Dec 2025 00:00:00 GMT</pubDate>
      <category>Weight loss</category>
      <description>The first oral GLP-1 for weight loss, launched January 2026 at $149–$299/month by dose through NovoCare and retail cash programs. Source: https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults-302648344.html</description>
    </item>
  </channel>
</rss>